The big supply chain disruptor is the regulators, say shippers
Shippers need their supply chain partners to collaborate in order to speed up processes and ...
Despite heavy marketing by some carriers and forwarders, standards in pharmaceutical logistics are not always as good as are billed, and should be further standardised, according to one pharma shipper.
Yulia Celetaria, head of logistics for Early Health Group, should know: she was global pharma director for Volga-Dnepr Group and AirBridgeCargo before making the rare move to become a shipper.
“There is often zero understanding among some shippers about the airline industry,” she told The Loadstar on the sidelines of the ACE ...
Volcanic disruption at Anchorage could hit transpacific airfreight operations
Shippers snap up airfreight capacity to US ahead of tariff deadline
New price hikes may slow ocean spot rate slide – but for how long?
Tighter EU import requirements proving 'a challenge' for forwarders
Supply chain delays expected after earthquake hits Myanmar
Forwarders stay cool as US 'liberation day' tariffs threaten 'global trade war'
Looming Trump tariffs will create 'a bureaucratic monster' for Customs
Comment on this article
Alan Kennedy
December 07, 2023 at 4:59 pmThis article contains some interesting and widely-held viewpoints. It is issues like these that have recently led to the industry coming together to take a collaborative approach to pharma Good Distribution Practice and regulatory compliance.
The non-profit GDP-UCI (Universal Compliance Initiative) has the goals of introducing new concepts for achieving, demonstrating and recording GDP compliance; of introducing the means for meaningful GDP measurement for comparison, benchmarking and continuous improvement purposes; and of creating abmore harmonised GDP training environment.
It is achieving these goals through the involvement and alignment of all the supply chain parties and disciplines that are involved in, or affected by, the GDP regulations and guidelines and, it is this collaborative approach that distinguishes it from other industry bodies that are active in this space.
GDP-UCI is a democratically-governed social enterprise that is neutral, fully independent and open to all organisations that are active in the field of pharmaceutical distribution.